Nanda Provoost
Nanda Provoost has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Antonie J P van Tilburg
Department of Gastroenterology and Hepatology, Franciscus Gasthuis , Rotterdam
1 shared publicationArjun D Koch
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center , Rotterdam
1 shared publicationEdith M Koehler
Department of Gastroenterology and Hepatology, Ikazia Hospital , Rotterdam
1 shared publicationElisabeth P C Plompen
Department of Gastroenterology and Hepatology, IJsselland Hospital , Capelle aan den IJssel
1 shared publicationHüseyin Aktaş
Department of Gastroenterology and Hepatology, Ziekenhuisgroep Twente , Almelo
1 shared publicationJudith Honing
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center , Rotterdam
1 shared publication
Latest Publications
- 2 March 2026
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 39 (2)
Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus
Summary: Verrucous carcinoma of the esophagus (VCE) is a rare variant of squamous cell carcinoma that poses diagnostic challenges due to nonspecific endoscopic and histologic findings. Its typical Candida overgrowth and hyperkeratotic, non-malignant superficial layer, combined with biopsy results showing fungal hyphae and minimal cytological atypia, are often misleading. Consequently, VCE is frequently diagnosed at advanced stages, limiting curative treatment options and contributing to poor outcomes. Clinicians should consider VCE in patients with persistent verrucous or hyperkeratotic esophageal lesions, especially in the setting of chronic Candida esophagitis. In this commentary, we reflect on seven cases diagnosed at a Dutch tertiary referral center to illustrate diagnostic pitfalls, discuss various treatment options, and offer guidance for improved recognition of VCE. By facilitating earlier diagnosis, curative treatment through endoscopic resection becomes more feasible, ultimately improving patient outcomes.
- 2 March 2026
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 39 (2)
Lessons learned: the importance of timely recognition of verrucous squamous cell carcinoma in the esophagus
Summary: Verrucous carcinoma of the esophagus (VCE) is a rare variant of squamous cell carcinoma that poses diagnostic challenges due to nonspecific endoscopic and histologic findings. Its typical Candida overgrowth and hyperkeratotic, non-malignant superficial layer, combined with biopsy results showing fungal hyphae and minimal cytological atypia, are often misleading. Consequently, VCE is frequently diagnosed at advanced stages, limiting curative treatment options and contributing to poor outcomes. Clinicians should consider VCE in patients with persistent verrucous or hyperkeratotic esophageal lesions, especially in the setting of chronic Candida esophagitis. In this commentary, we reflect on seven cases diagnosed at a Dutch tertiary referral center to illustrate diagnostic pitfalls, discuss various treatment options, and offer guidance for improved recognition of VCE. By facilitating earlier diagnosis, curative treatment through endoscopic resection becomes more feasible, ultimately improving patient outcomes.
- Open Access
- 6 February 2025
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 75, 101989
Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives
- 6 February 2025
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 75, 101989
Open AccessBarrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives